Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/31/2007CN101062047A Combination including isoglycyrrhizinate and oxymatrine and the purpose thereof
10/31/2007CN101062046A Medical function of saponin component
10/31/2007CN101062045A Novel function of triterpene saponin compounds
10/31/2007CN101062044A Medicine combination including high-concentration polydatin
10/31/2007CN101062043A Application of 3, 4, 5, 4'-tetramethyl diphenylethane-3'-O-disodium phosphate in the anti-cancer medicine and the transferring medicine thereof
10/31/2007CN101062042A Compound vibramycin injection for animals and the preparing method thereof
10/31/2007CN101062041A Novel medical function of cucurbitacin
10/31/2007CN101062040A Stable type cucurbitacin liquid formula and the agent thereof
10/31/2007CN101062039A Medical combination for treating nervous system diseases
10/31/2007CN101062038A Candesartan hydrochlorothiazide dispersible tablets and the preparing method thereof
10/31/2007CN101062037A Thioxanthine derivatives, process for their preparation (variants), their use and composition containing them
10/31/2007CN101062036A 5-(4-(2-n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl thiazolidine - 2,4-dione and pharmaceutical compositions comprising the same
10/31/2007CN101062035A Therapeutic combinations comprising amlodipin and atorvastatin
10/31/2007CN101062034A Lappaconitine Hydrobromide transdermal gel and the preparing method thereof
10/31/2007CN101062033A Medicine combination for treating inflammation of vagina
10/31/2007CN101062032A Sulbactam sodium bacteriophage complex and the preparing method thereof
10/31/2007CN101062031A Method of controlling the quality of silymarin oral aolid preparation
10/31/2007CN101062030A Method of preparing silybin frozen powder injection
10/31/2007CN101062029A Application of wogonin in the preparing of medicine for treating gastric cancer
10/31/2007CN101062028A Combination including taxanes, the preparing method and the use thereof
10/31/2007CN101062027A Taurine and medical combination for treating cardiovascular and cerebrovascular diseases
10/31/2007CN101062026A Function of pseudolarix acetic acid as medicine for inducing tumor cells to die
10/31/2007CN101062025A Compound anget for reducing weight, fat, sugar, pressure and for preventing and treating osteoporosis
10/31/2007CN101062024A Pronin medicinal composition and its preparing method
10/31/2007CN101062023A Selective androgen receptor modulators and methods of use thereof
10/31/2007CN101062022A Colchicine patch absorbing from skin for treating acute goute arthritis and the preparing method thereof
10/31/2007CN101062021A Diarrhea treating medical composition
10/31/2007CN101062020A Tiotropium bromide capsule type dry powder inhalations and the preparing method thereof
10/31/2007CN101062019A Lappaconitine hydrobromide transparent patch and the preparing method thereof
10/31/2007CN101062018A Hydrochloride clindamycin palmitate soft capsule and the preparing method thereof
10/31/2007CN101062017A Hyaluronic acid and preparation process thereof
10/31/2007CN101062016A Immune micro-liposomal used in the cancer developing, diagnosing and treating and the application thereof
10/31/2007CN101062014A Compound hydrochloride doxycycline injection for animals and the preparing method thereof
10/31/2007CN101062013A Hydrochloride doxycycline injection for animals and the preparing method
10/31/2007CN101062012A Narcotic analgesics injection liquid
10/31/2007CN101062011A Calcium dobesilate injection
10/31/2007CN101061887A Cancer-proof cigarette made by paclitaxel and the method of producing the same
10/31/2007CN101061861A Health-care hypoglycermic food and its preparing method
10/31/2007CN101061860A Leucine-rich nutritional compositions
10/31/2007CN100345978C Anaplastic lymphoma kinase assay, reagents and compositions thereof
10/31/2007CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007CN100345860C New 3-decladinosyl 9a-n -carbamoyl and 9a-n -thiocarbamoyl derivatives of 9-deox-9-dihydro-9a-aza-9a-homoerythromycin a
10/31/2007CN100345859C Antitumor compound nobiliside A from Holathuria nobilis and its monoacetylated derivative
10/31/2007CN100345853C Pyrazolopyrimidine compound and method for producing the same
10/31/2007CN100345852C Quinolinyl-pyrrolopyrazoles
10/31/2007CN100345850C Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
10/31/2007CN100345849C Enantiomer (-) of tenatoprazole and the therapeutic use thereof
10/31/2007CN100345847C Novel biarylcarboxamides
10/31/2007CN100345846C Sodium sal ts of 5'-4'-2-(N-methyl-N-(2-pyridyl)amino) ethoxy [benzyl] thiazolidine-2,4-dione
10/31/2007CN100345844C Quinazoline derivatives for the treatment of tumours
10/31/2007CN100345843C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
10/31/2007CN100345842C Dimeric compounds and their use as anti-viral agents
10/31/2007CN100345840C Stable hydrate of a muscarinic receptor antagonist
10/31/2007CN100345839C Reduced aminate of geniposide huperzine A and its preparation method and uses
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345833C Modulators of dopamine neurotransmission
10/31/2007CN100345830C Condensed heteroaryl derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345827C Bicyclic aromatic compound
10/31/2007CN100345823C Compounds, compositions and methods
10/31/2007CN100345810C Novel natural drug effective region of rabdosiaexcisa total diterpene
10/31/2007CN100345625C Novel adsorbent
10/31/2007CN100345596C medicinal aerosol formulation
10/31/2007CN100345594C Acetazolamide eye droplet and its application method in treating glaucoma
10/31/2007CN100345593C Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/31/2007CN100345589C Essential element nutritive preparation for intestine
10/31/2007CN100345586C Chinese traditional medicine and western medicine composition for treating hepatitis
10/31/2007CN100345582C Medicine for abstaining from drug
10/31/2007CN100345578C Medicine for auxiliary treating hepatitis
10/31/2007CN100345560C Ointment for treating osteoproliferation and protrusion of intervertebral discand preparing method
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/31/2007CN100345551C Preparation of elaioplast and lipid compound preparation of nucleoside-phosphate compound
10/31/2007CN100345550C Compound eye drops for treating electro-optic harmed eye
10/31/2007CN100345549C Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
10/31/2007CN100345548C Drug for treating fractures
10/31/2007CN100345547C Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
10/31/2007CN100345546C Orally quick disintegrating lornoxicam composition and its prepn process
10/31/2007CN100345545C 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect
10/31/2007CN100345544C Nicergoline oral cavity disintegration tablet and its preparation method
10/31/2007CN100345543C Use of plant growth regulator for insect
10/31/2007CN100345542C Tinizadole dental plaster for treating buccal inflammation
10/31/2007CN100345541C Microcapsules for the delayed, controlled release of perindopril
10/31/2007CN100345540C Use of ampelopsin in preparing medicine for treating diseases related with aldose reductase
10/31/2007CN100345539C Composition containing dihydro myricitrin and myricitrin
10/31/2007CN100345538C Use of ampelopsin for preparing blood sugar reducing medicine
10/31/2007CN100345537C Application wogonin for preparing medicine to treat leukaemia
10/31/2007CN100345536C Pharmaceutical composition comprising 5-methyl-2-2'(chloro-6'-fluoroanilino) phenylacetic acid
10/31/2007CN100345533C Asiabell polysaccharide tablet of asiabell effective ingredient
10/31/2007CN100345522C Spine distraction implant
10/30/2007US7288680 Benzotropolone derivatives and modulation of inflammatory response
10/30/2007US7288662 Process for the preparation of eletriptan
10/30/2007US7288660 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
10/30/2007US7288659 Acylaminothiazole derivatives, their preparation and therapeutic use
10/30/2007US7288657 Biphenyl compounds useful as muscarinic receptor antagonists
10/30/2007US7288654 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation
10/30/2007US7288653 6-7-8-9-Tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime derivatives such as 5-phenyl-6-7-8-9-tetrahydro-1H-pyrrolo-[3,2-h]-isoquinoline-2,3-dione-3-oxime; sodium channel modulators; antiischemic agents
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288570 Stimulation of in vivo production of proteins
10/30/2007US7288569 treating vasoconstriction by administering purified 15-epi-lipoxins compounds such as 15R-5,6,15-trihydroxy-7, 9, 13-trans-11-cis-eicosatetraenoic acid, stereoisomers and a pharmaceutically acceptable carriers
1 ... 3525 3526 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 ... 7860